Nancy S Shulman, MD
Infectious Disease · San Mateo
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · County of San Mateo · 316 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Shulman’s office at (650) 573-2222 to ask if they take your plan before you enroll.
California Medical Board record
Licence G82023 · Current
Licensed to practise in California · since 1995 · expires 2027-11-30 · University of Kansas School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
$200,750
Pharmacies billed $200,750 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 7% of their Part D prescriptions (24 of 335) in 2024. A higher opioid share than 9 in 10 peers; the typical infectious disease clinician is at 0%. Long-acting opioids: 46% of their opioid prescriptions.
247 generic and 88 brand-name prescriptions · $200,750 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Biktarvy | 23 | $111,082 | $4,830 |
| Triumeq | 18 | $68,030 | $3,779 |
| Ozempic | 15 | $13,927 | $928 |
| Albuterol Sulfate Hfa | 11 | $574 | $52 |
| Gabapentin | 19 | $377 | $20 |
See all 12 drugs
| Biktarvy | 23 | $111,082 | $4,830 |
| Triumeq | 18 | $68,030 | $3,779 |
| Ozempic | 15 | $13,927 | $928 |
| Albuterol Sulfate Hfa | 11 | $574 | $52 |
| Gabapentin | 19 | $377 | $20 |
| Morphine Sulfate Er | 11 | $170 | $15 |
| Oxycodone-Acetaminophen | 11 | $163 | $15 |
| Ibuprofen | 14 | $104 | $7 |
| Metformin | 28 | $52 | $2 |
| Atorvastatin | 11 | $28 | $3 |
| Amlodipine Besylate | 21 | $21 | $1 |
| Lisinopril | 14 | $15 | $1 |
Year by year
| 2024 | 335 | None | 7% (24) | 26% | $200,750 |
| 2023 | 332 | None | 5% (15) | 25% | $213,865 |
| 2022 | 296 | None | 8% (23) | 28% | $231,720 |
| 2021 | 241 | None | 8% (18) | 33% | $252,471 |
| 2020 | 253 | None | 5% (12) | None | $245,003 |
| 2019 | 208 | None | 8% (17) | 36% | $213,717 |
| 2018 | 130 | None | 19% (24) | 27% | $75,971 |
| 2017 | 60 | None | None | 40% | $42,555 |
| 2016 | 38 | None | 40% (15) | None | $8,177 |
| 2015 | 105 | None | None | 33% | $62,996 |
| 2014 | 53 | None | 23% (12) | 45% | $30,069 |
| 2013 | 83 | None | 23% (19) | 27% | $28,838 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 11 drugs
| Biktarvy | 32 | $137,936 | $4,310 |
| Triumeq | 13 | $50,178 | $3,860 |
| Ozempic | 12 | $11,797 | $983 |
| Gabapentin | 27 | $1,247 | $46 |
| Methocarbamol | 12 | $398 | $33 |
| Metformin | 37 | $219 | $6 |
| Amlodipine Besylate | 18 | $158 | $9 |
| Lisinopril | 15 | $140 | $9 |
| Omeprazole | 17 | $137 | $8 |
| Ibuprofen | 12 | $126 | $11 |
| Atorvastatin | 16 | $120 | $7 |
2022: 11 drugs
| Biktarvy | 33 | $142,317 | $4,313 |
| Juluca | 11 | $33,960 | $3,087 |
| Prezcobix | 12 | $26,448 | $2,204 |
| Gabapentin | 16 | $915 | $57 |
| Albuterol Sulfate Hfa | 18 | $869 | $48 |
| Morphine Sulfate Er | 16 | $253 | $16 |
| Metformin | 30 | $139 | $5 |
| Lisinopril | 17 | $112 | $7 |
| Simvastatin | 12 | $51 | $4 |
| Omeprazole | 15 | $51 | $3 |
| Atorvastatin | 13 | $33 | $3 |
2021: 7 drugs
| Biktarvy | 43 | $167,635 | $3,898 |
| Albuterol Sulfate Hfa | 11 | $574 | $52 |
| Gabapentin | 18 | $292 | $16 |
| Morphine Sulfate Er | 12 | $200 | $17 |
| Ibuprofen | 18 | $150 | $8 |
| Atorvastatin | 11 | $31 | $3 |
| Omeprazole | 11 | $20 | $2 |
2020: 7 drugs
| Biktarvy | 41 | $135,322 | $3,301 |
| Gabapentin | 19 | $176 | $9 |
| Metformin | 18 | $57 | $3 |
| Simvastatin | 16 | $57 | $4 |
| Atorvastatin | 12 | $42 | $3 |
| Amlodipine Besylate | 12 | $24 | $2 |
| Omeprazole | 12 | $24 | $2 |
2019: 6 drugs
| Biktarvy | 25 | $88,291 | $3,532 |
| Morphine Sulfate Er | 11 | $176 | $16 |
| Gabapentin | 15 | $149 | $10 |
| Metformin | 15 | $49 | $3 |
| Simvastatin | 12 | $49 | $4 |
| Lisinopril | 11 | $31 | $3 |
2018: 2 drugs
| Morphine Sulfate Er | 16 | $289 | $18 |
| Lisinopril | 12 | $30 | $3 |
2017: 2 drugs
| Atripla | 16 | $41,171 | $2,573 |
| Metformin | 14 | $30 | $2 |
2015: 1 drug
| Levothyroxine | 38 | $274 | $7 |
2014: 1 drug
| Atripla | 12 | $25,128 | $2,094 |
2013: 4 drugs
| Atripla | 13 | $25,288 | $1,945 |
| Metformin | 13 | $133 | $10 |
| Sulfamethoxazole-Trimethoprim | 11 | $96 | $9 |
| Hydrocodone-Acetaminophen | 11 | $92 | $8 |
Money from drug and device companies
$151 in 2025
A payment is not proof that care is biased.
| E.R. Squibb & Sons L.L.C. | Cobenfy | $151 | 2 payments
|
See all 2 published payments
| E.R. Squibb & Sons L.L.C. | Meals · 2025-02-07 | Cobenfy | $94 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-01-13 | Cobenfy | $57 |
Professional record
- NPI
- 1356498091
- Licence
- CA G82023California G82023: Current · expires 2027-11-30
- Trained
- Kansas City University of Physicians and Surgeons, 1991
- Group
- County of San Mateo
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207RI0200X (207RI0200X)
- Mailing address
- 626 Wildwood Ln, Palo Alto, CA, 94303
- NPI first listed
- 2007-01-04
- NPI last updated
- 2007-07-08
This is when the NPI record was last certified, not a medical board exam.